retatrutide phase 2 diabetes weight loss 2024 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending Efficacy and safety of retatrutide,

This is generally temporary and resolves as weight stabilizes, but should be discussed with a healthcare provider if it persists beyond a few months

The data: Most patients who got prescribed a GLP-1 for the first time in 2023 or 2024 ended up discontinuing treatment before long, and many never filled their prescription at all, according to a November 2025 IQVIA analysis of GLP-1 prescription claims

Excess adiposity, particularly visceral fat, is associated with impaired incretin effect in type 2 diabetes

During your consultation, you'll provide a complete medication list for review

We carefully review your medical history, weight loss goals, and potential risks